Wenora Johnson/LinkedIn
Apr 14, 2025, 10:04
Wenora Johnson: Understanding My Genetic Predisposition Led to a Lifesaving Clinical Trial for Lynch Syndrome
Wenora Johnson, Administrative Support – Chain Reaction Innovations at Argonne National Laboratory and Research, shared FORCE: Facing Our Risk of Cancer Empowered’s post on LinkedIn:
“Understanding my genetic predisposition, led to an opportunity to be in a Clinical Trial for Lynch Syndrome knowing can be lifesaving!”
Quoting FORCE: Facing Our Risk of Cancer Empowered’s post on LinkedIn:
“Check out this Black Health Matters article on understanding genetic predispositions to cancer featuring FORCE VP of Health Education and Communication, Juanita Rogers, Partnerships Strategy Manager, Varinda Hobbs, and our FORCE Board President Wenora Johnson. Get empowered!”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 10, 2025, 10:26
May 10, 2025, 10:24
May 10, 2025, 10:15